UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-29579
---------
U.S. MEDICAL GROUP, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
1405 South Orange Avenue, Suite 601, Orlando, Florida 32806, (407) 849-2288
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock, par value $0.001 per share
----------------------------------------
(Title of Class of Securities)
None
----------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [ ] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice
date: 266
----
Pursuant to the requirements of the Securities Exchange Act of 1934, U.S.
Medical Group, Inc., a Nevada corporation, has caused this certification/notice
to be signed on its behalf by the undersigned duly authorized person.
Date: February 4, 2002 By: /s/ Thomas F. Winters
--------------------- ------------------------------------------------
Thomas F. Winters, M.D., Chief Executive Officer